FRM
TMDX icon

Fox Run Management’s Transmedics TMDX Stock Holding History

Fox Run Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,939
Closed -$1.12M – 1260
2025
Q3 		$1.12M Buy
9,939
+1,736
+21% +$203K 0.17% 174
2025
Q2 		$1.1M Buy
+8,203
New +$901K 0.18% 162

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Fox Run Management's TMDX Position: Q4 2025 in Review

Fox Run Management sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 9,939 shares — an estimated $1.12M sold.

Fox Run Management first reported a position in TMDX in Q2 2025 and held it in 2 quarters. The position peaked at $1.12M in Q3 2025. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • Fox Run Management reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • Fox Run Management sold 9,939 Transmedics shares in Q4 2025, an estimated $1.12M.
  • Fox Run Management first reported a position in Transmedics in Q2 2025 and held it in 2 quarters.
  • Fox Run Management's Transmedics position peaked at $1.12M in Q3 2025.
  • 428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Fox Run Management's 13F filing for Q4 2025, filed 11 Feb 2026.